MANNINI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 2.404
EU - Europa 2.013
AS - Asia 1.398
SA - Sud America 197
OC - Oceania 25
AF - Africa 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.057
Nazione #
US - Stati Uniti d'America 2.378
PL - Polonia 762
RU - Federazione Russa 662
SG - Singapore 416
CN - Cina 393
HK - Hong Kong 175
KR - Corea 171
IT - Italia 157
BR - Brasile 153
IE - Irlanda 109
SE - Svezia 89
IN - India 75
VN - Vietnam 74
DE - Germania 68
FI - Finlandia 60
CH - Svizzera 30
ID - Indonesia 27
AU - Australia 25
GB - Regno Unito 24
AR - Argentina 15
TR - Turchia 13
JO - Giordania 12
ES - Italia 11
MX - Messico 11
CA - Canada 10
FR - Francia 9
NL - Olanda 9
EC - Ecuador 7
IQ - Iraq 7
JP - Giappone 7
BD - Bangladesh 6
PY - Paraguay 6
BJ - Benin 5
CO - Colombia 5
AL - Albania 4
UA - Ucraina 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
CI - Costa d'Avorio 3
LT - Lituania 3
MA - Marocco 3
PE - Perù 3
UY - Uruguay 3
VE - Venezuela 3
AM - Armenia 2
DZ - Algeria 2
IR - Iran 2
MY - Malesia 2
PA - Panama 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CM - Camerun 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
LB - Libano 1
PH - Filippine 1
PT - Portogallo 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.057
Città #
Santa Clara 764
Warsaw 762
Singapore 301
Ashburn 247
Hefei 179
Fairfield 177
Seoul 161
Hong Kong 158
Chandler 126
Dublin 109
Seattle 85
Woodbridge 78
Houston 69
Wilmington 69
Cambridge 66
Florence 47
San Jose 44
Lawrence 41
Beijing 40
Moscow 40
Altamura 36
Los Angeles 36
Mumbai 28
Buffalo 26
Princeton 26
Ho Chi Minh City 24
Melbourne 24
Pune 24
Munich 23
Ann Arbor 22
Bremen 22
Jakarta 22
Kent 21
Boston 20
Helsinki 18
The Dalles 16
Boardman 15
Turku 15
Shanghai 14
Dallas 13
Hanoi 13
Lappeenranta 13
San Diego 13
Basel 12
Dong Ket 12
Medford 10
Bengaluru 9
Bern 9
Council Bluffs 9
Seongnam 9
Barcelona 8
Milan 8
Norwalk 8
São Paulo 8
Cagliari 7
Chennai 7
Clifton 7
Dübendorf 7
Falls Church 7
Jacksonville 7
Belo Horizonte 6
Brasília 6
Groningen 6
London 6
Rio de Janeiro 6
Serra 6
Cotonou 5
Denver 5
Haiphong 5
Hillsboro 5
Izmir 5
Manchester 5
Paris 5
Phoenix 5
Rome 5
Tianjin 5
Chicago 4
Frankfurt am Main 4
New York 4
Tirana 4
Abidjan 3
Amman 3
Asunción 3
Atlanta 3
Baghdad 3
Canoas 3
Carmignano 3
Da Nang 3
Draper 3
Duque de Caxias 3
Guadalupe 3
Johannesburg 3
Montevideo 3
Nuremberg 3
Orem 3
Orenburg 3
Ottawa 3
Redwood City 3
São Bernardo do Campo 3
Tokyo 3
Totale 4.353
Nome #
A causative link between the structure of aberrant protein oligomers and their toxicity 380
Large proteins have a great tendency to aggregate but a low propensity to form amyloid fibrils 320
Effect of molecular chaperones on aberrant protein oligomers in vitro: super- versus sub-stoichiometric chaperone concentrations 281
Early-forming aberrant aggregates in protein deposition diseases: structural characteristics, interaction with molecular chaperones, ability to trigger inflammation 269
Toxic HypF-N oligomers selectively bind the plasma membrane to impair cell adhesion capability 252
Multistep Inhibition of α‑Synuclein Aggregation and Toxicity in Vitro and in Vivo by Trodusquemine 221
Chaperones as Suppressors of Protein Misfolded Oligomer Toxicity 188
The induction of α-helical structure in partially unfolded HypF-N does not affect its aggregation propensity 179
Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers 176
Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N 175
A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells 169
Glycosaminoglycans (GAGs) Suppress the Toxicity of HypF-N Prefibrillar Aggregates 166
Bis(indolyl)phenylmethane derivatives are effective small molecules for inhibition of amyloid fibril formation by hen lysozyme 153
SERS Detection of Amyloid Oligomers on Metallorganic-Decorated Plasmonic Beads 147
Differential interactome and innate immune response activation of two structurally distinct misfolded protein oligomers 146
Trodusquemine displaces protein misfolded oligomers from cell membranes and abrogates their cytotoxicity through a generic mechanism 142
Squalamine and its derivatives modulate the aggregation of amyloid-β and α-synuclein and suppress the toxicity of their oligomers 139
Salt anions promote the conversion of HypF-N into amyloid-like oligomers and modulate the structure of the oligomers and the monomeric precursor state. 135
Distinct responses of human peripheral blood cells to different misfolded protein oligomers 129
Aβ oligomers dysregulate calcium homeostasis by mechanosensitive activation of AMPA and NMDA receptors. 129
Chaperones suppress protein oligomer toxicity: Insight into the molecular mechanism of action 128
Chaperones suppress the toxicity of aberrant protein aggregates. Molecular insight into the mechanism of action 116
Small-molecule sequestration of amyloid-beta. as a drug discovery strategy for Alzheimer's disease 114
Toxicity of Protein Oligomers Is Rationalized by a Function Combining Size and Surface Hydrophobicity 113
Exogenous misfolded protein oligomers can cross the intestinal barrier and cause a disease phenotype in C. elegans 110
Stabilization and Characterization of Cytotoxic Aβ40 Oligomers Isolated from an Aggregation Reaction in the Presence of Zinc Ions 108
The Pathological G51D Mutation in Alpha-Synuclein Oligomers Confers Distinct Structural Attributes and Cellular Toxicity 103
Two human metabolites rescue a C. elegans model of Alzheimer’s disease via a cytosolic unfolded protein response 99
A Relationship between the Structures and Neurotoxic Effects of Aβ Oligomers Stabilized by Different Metal Ions 99
Rationally designed antibodies as research tools to study the structure–toxicity relationship of amyloid-β oligomers 99
A rationally designed bicyclic peptide remodels Aβ42 aggregation in vitro and reduces its toxicity in a worm model of Alzheimer’s disease 97
Therapeutic strategies to reduce the toxicity of misfolded protein oligomers 95
Delivery of Native Proteins into C. Elegans Using a Transduction Protocol Based on Lipid Vesicles 95
Proteome-wide observation of the phenomenon of life on the edge of solubility 92
Rational design of a conformation-specific antibody for the quantification of Aβ oligomers 91
Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates 89
Systematic development of small molecules to inhibit specific microscopic steps of Aβ42 aggregation in Alzheimer's disease 88
Preparation and Characterization of Zn(II)-Stabilized Aβ42 Oligomers 86
Structure-Based Discovery of Small-Molecule Inhibitors of the Autocatalytic Proliferation of α-Synuclein Aggregates 84
Single molecule secondary structure determination of proteins through infrared absorption nanospectroscopy 83
Small Molecule Inhibitors for Precise Inhibition of Alpha-Synuclein Oligomer Generation in Parkinson’s Disease (S32.002) 82
A dopamine metabolite stabilizes neurotoxic amyloid-β oligomers 81
Targeting Protein Aggregation in ALS 80
Berberine mitigates neurotoxicity of misfolded protein oligomers by interacting with the cell membrane and subsequent internalization, without altering their structure 12
Totale 6.140
Categoria #
all - tutte 16.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 0 0 0 18 24 41 51 19 26
2021/2022162 1 25 16 5 3 7 8 14 10 9 18 46
2022/2023562 37 109 36 52 44 104 66 32 50 3 16 13
2023/2024274 9 28 27 9 9 42 10 50 4 61 14 11
2024/20252.010 49 215 87 266 662 259 41 64 125 41 83 118
2025/20261.591 255 361 338 215 253 109 60 0 0 0 0 0
Totale 6.140